Inclusion Criteria:  Patients (children and adults) developing acute or chronic GvHD after HSCT. Age 6 months- month-99 years, Landsky-Karnofsky> 70%, Acute or chronic GvHD needing further immunosuppressive treatment.  Exclusion Criteria:  Anything not included in the inclusion criteria.